Aclaris Therapeutics, Inc.

A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.

ACRS | NDAQ

Overview

Corporate Details

ISIN(s):: US00461U1051
LEI:
Country:: United States of America
Address:: 701 LEE ROAD, 19087 WAYNE
Website:: https://www.aclaristx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. The company aims to translate scientific discovery into therapeutic solutions for underserved conditions. Aclaris leverages its core expertise in drug discovery, development, and kinase inhibition to advance a pipeline of innovative small and large molecule drugs designed to address significant unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Aclaris Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aclaris Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Aclaris Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Clearside Biomedical, Inc. Developing therapies for back-of-the-eye diseases via proprietary suprachoroidal delivery.	United States of America	CLSD
Clene Inc. Developing nanocrystal therapies for neurodegenerative diseases like ALS and MS.	United States of America	CLNN
Climb Bio, Inc. Clinical-stage biotech developing monoclonal antibodies for immune-mediated diseases.	United States of America	CLYM
CMG Pharmaceutical Co., Ltd. Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.	South Korea	058820
Cocrystal Pharma, Inc. Develops novel antiviral drugs for influenza, coronaviruses, norovirus, and hepatitis C.	United States of America	COCP
Co-Diagnostics, Inc. Develops patented PCR solutions for accurate infectious disease diagnostics.	United States of America	CODX
co.don AG Develops personalized cartilage cell transplants for minimally invasive joint repair.	Germany	CNW
Coeptis Therapeutics Holdings, Inc. Develops cell therapy platforms for cancer, autoimmune, and infectious diseases.	United States of America	COEP
COGNITION THERAPEUTICS INC Clinical-stage biopharma developing small-molecule drugs for Alzheimer's and dementia.	United States of America	CGTX
Coherus Oncology, Inc. Commercial-stage biopharma developing immuno-oncology therapies for hard-to-treat cancers.	United States of America	CHRS